Early-Stage Aerospace Startup Pursues NSF Funding
An early-stage aerospace startup engaged BW&CO to pursue non-dilutive research funding through the National Science Foundation. Working as an embedded extension of the founding team, BW&CO led the strategic positioning, drafted the submission, managed the timeline, and handled the administrative lift required to compete credibly. The engagement gave the company a clear path into the NSF funding pipeline while preserving founder focus and equity.
From Transactional Asks to Strategic Coalition-Building: Repositioning a Pre-Clinical Pharma Company for DoD Funding
A pre-clinical stage pharmaceutical company developing a novel therapeutic platform engaged BW&CO to pursue Department of Defense funding opportunities aligned with its clinical and commercial objectives. What began as support for a single proposal evolved into a broader strategic engagement, with BW&CO reframing how the company approaches stakeholder alignment, evaluator psychology, and the role of supporting documentation in competitive federal funding pursuits.
When Military End-User Validation Unlocks a New Funding Conversation
BW&CO partnered with a VC-backed human performance startup navigating the AFWERX Direct-to-Phase-II program to do what the award process alone cannot: connect the technology to the right military end user at the right moment. That connection didn't just validate the solution — it opened an entirely new funding conversation the client hadn't anticipated walking in the door.
Three Teaming Meetings in 24 Hours: How BW&CO Accelerated an ARPA-H Pursuit
When a biotech/life sciences company set its sights on an ARPA-H funding opportunity, it faced an immediate and high-stakes challenge: it needed credible teaming partners — fast. BW&CO stepped in and, within 24 hours, had scheduled three introductory meetings with potential partners from well-regarded organizations whose involvement would meaningfully strengthen the client's proposal. What could have taken weeks of outreach and relationship-building was compressed into a single business day, giving the client critical momentum at a pivotal point in the competitive process.
Securing Federal Validation for a Next-Generation Epigenetic Diagnostic Platform
A pioneering epigenetic diagnostics company had developed a novel systems-based framework for mapping how DNA methylation changes over time — work with significant implications for chronic disease prediction, personalized treatment, and drug discovery. To advance the science, they needed federal funding and the credibility that comes with it. BW&CO partnered with the company to build and execute a competitive NIH SBIR application strategy, resulting in a Phase I award of over $300K that validated the technology and opened the door to the next stage of research and commercialization.
How BW&CO Helped a Women-Owned MedTech Startup Win a $312,559 NIH Phase I SBIR Award
A women-owned, socially and economically disadvantaged medical device startup had developed a novel approach to reducing healthcare-acquired infections (HAIs) — a persistent and costly problem in clinical settings nationwide. The company needed to translate compelling preliminary research into a competitive federal grant application. BW&CO partnered with the founding team to develop and submit a Phase I SBIR application to the CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), securing a $312,559 award that will fund the next stage of product validation and research.
Virtual Marketplace for Community Solar Access Wins Federal DOE Recognition
BW&CO partnered with a mission-driven technology startup to pursue a competitive federal funding opportunity through the U.S. Department of Energy. By providing end-to-end proposal development and project management support, BW&CO helped the team successfully secure a DOE award — validating their innovative platform and opening the door to broader impact for underserved communities across the country.
From Concept to Funded: $306,865 Phase I NIH SBIR Award Secured for Breakthrough Nanoemulsion Research
A small biotech R&D firm with patented ultrasonic technology and deep scientific expertise needed more than good science to win federal funding — it needed a compelling, strategically structured proposal that could cut through one of the most competitive grant programs in the country. BW&CO partnered with the firm across the full arc of the engagement, from shaping the funding strategy to delivering a polished, submission-ready application. The result: a $306,865 Phase I Small Business Innovation Research (SBIR) award from the National Institutes of Health's National Center for Complementary and Integrative Health (NCCIH), validating the company's research direction and unlocking the capital needed to advance their work toward commercialization.
Biotechnology Startup Secures $209,565 SBIR Phase I Award for Breakthrough Vaccine Stabilization Technology
BW&CO partnered with an early-stage biotechnology company developing revolutionary vaccine preservation technology to secure a competitive Department of Defense SBIR Phase I award. Through comprehensive proposal development and strategic positioning, we helped the client articulate their breakthrough approach to thermal stabilization of biologicals, positioning them to address critical supply chain vulnerabilities in medical countermeasures while advancing their proprietary dehydration technology toward commercialization.
Bridging the Gap Between the Shop Floor and the Field
When an advanced manufacturing technology company needed to translate a promising portable fabrication platform into a compelling case for military adoption, they turned to BW&Co. for end-to-end proposal support. The result: a successful AFWERX SBIR Phase I award worth $74,689 to develop a user-friendly, automated system capable of performing maintenance, manufacturing, and demolition in deployed, austere environments — putting capabilities once confined to specialized shops directly in the hands of Air Force personnel in the field.
Securing $3M in Federal Funding for a Neurotechnology Innovator
BW&CO partnered with an early-stage neurotechnology company to pursue a highly competitive federal research award through the Congressionally Directed Medical Research Programs (CDMRP) Joint Warfighter Medical Research Program (JWMRP). From initial strategy development through award execution, BW&CO provided end-to-end support — enabling the client to secure more than $3 million in funding and position their technology for continued advancement in a demanding federal research environment.
From Concept to Contract: Securing Federal Validation for a Breakthrough Waste-to-Energy Technology
BW&CO helped ENVERDE secure a $109,929 AFWERX STTR Phase I award with full-cycle proposal writing, strategy, and project management support.
From Zero to Award in Four Weeks: Full-Cycle SBIR Support on an Accelerated Timeline
When a California-based AI technology company identified a compelling SBIR opportunity with the Department of Defense, they had the technical vision — but not the time, bandwidth, or proposal infrastructure to pursue it alone. BW&CO delivered end-to-end support across strategy, writing, and administration, helping the company secure a $148,880 Phase I award under the AFWERX/OSD solicitation in under four weeks. What could have been an impossible deadline became a competitive win.